Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

Phase 3

2(25.0%)

Phase 1

1(12.5%)

N/A

1(12.5%)

8Total

Phase 2(4)

Phase 3(2)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02834312Phase 2Completed

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Role: collaborator

NCT02317705Phase 2Completed

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Role: collaborator

NCT02348359Phase 2Terminated

X-82 to Treat Age-related Macular Degeneration

Role: collaborator

NCT03180307Phase 3Completed

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Role: collaborator

NCT03216226Phase 3Completed

A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus

Role: collaborator

NCT03014115Not ApplicableCompleted

Effects of Different ARA Formulations of Infant Formula on Fatty Acid Status, Immune Markers and Infection Rates in Infants

Role: collaborator

NCT02594254Phase 2Completed

Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

Role: collaborator

NCT03931993Phase 1Completed

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

Role: collaborator

NCT02007473Completed

A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma

Role: collaborator

All 9 trials loaded